18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial
P. Harter, D. Petran, G. Scambia, E. Ortega, I. Tsibulak, S. Nagao, I. Vergote, J. Meunier, F. Priou, R. Sverdlin, T. Milenkova, I. Ray-Coquard
{"title":"18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial","authors":"P. Harter, D. Petran, G. Scambia, E. Ortega, I. Tsibulak, S. Nagao, I. Vergote, J. Meunier, F. Priou, R. Sverdlin, T. Milenkova, I. Ray-Coquard","doi":"10.1136/ijgc-2020-igcs.18","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":254448,"journal":{"name":"Oral Plenary","volume":"100 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Plenary","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2020-igcs.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
